Soon-Ah Park1, Kwang-Man Lee2, UnJong Choi2, Hun Soo Kim3, Hye-Won Kim4, Jeong Hoon Song5. 1. Department of Nuclear Medicine, Wonkwang University College of Medicine and Institute of Wonkwang Medical Science, Iksan, Republic of Korea. 2. Department of Surgery, Wonkwang University College of Medicine and Institute of Wonkwang Medical Science, 344-2 Shinyong-Dong, Iksan, Jeollabuk-do 570-749 Republic of Korea. 3. Department of Pathology, Wonkwang University College of Medicine and Institute of Wonkwang Medical Science, Iksan, Republic of Korea. 4. Department of Radiology, Wonkwang University College of Medicine and Institute of Wonkwang Medical Science, Iksan, Republic of Korea. 5. Department of Plastic and Reconstructive Surgery, Wonkwang University College of Medicine and Institute of Wonkwang Medical Science, Iksan, Republic of Korea.
Abstract
PURPOSE: The aim of this study was to evaluate the physiologic and benign F-18 fluorodeoxyglucose (FDG) avid foci in patients with breast cancer. METHODS: On 309 F-18 FDG PET/CT scans of 241 women with breast cancer, the hypermetabolic lesions compared with the surrounding normal region were evaluated retrospectively. Available reports of other relevant radiological imaging, medical records, and follow-up PET/CT were reviewed for explanations of the abnormal uptake. RESULTS: Among the 70 physiologic foci, muscular uptake of the lower neck following the surgical and/or radiation therapy of ipsilateral breast (29%), hypermetabolic ovaries (16%) and uterine (10%) uptake during the ovulatory and menstrual phases during the normal menstrual cycle were identified, and also hypermetabolic brown fat in cold-induced thermogenesis (7%), non-specific bowel uptake (35%) were observed. Among the 147 benign lesions, sequelae of the chest wall and breasts following surgical and/or radiation therapy, were often observed (27%). Hypermetabolic thyroid glands were noted as adenomas and chronic thyroiditis (18%). Reactive hyperplasia of cervical or mediastinal lymph nodes (32%), degenerative osteoarthritis and healed fractures (15%), hypermetabolic benign lung lesions (6%) were observed. CONCLUSION: Altered physiologic and benign F-18 FDG uptake in the lower cervical muscle and chest wall following ipsilateral breast surgery or radiotherapy were common, and also normal physiologic uptake in ovary and uterus, brown fat, thyroid were considered as predominant findings in women patients with breast cancer. Knowledge of these findings might aid in the interpretation of FDG PET/CT in patients with breast cancer.
PURPOSE: The aim of this study was to evaluate the physiologic and benign F-18 fluorodeoxyglucose (FDG) avid foci in patients with breast cancer. METHODS: On 309 F-18FDG PET/CT scans of 241 women with breast cancer, the hypermetabolic lesions compared with the surrounding normal region were evaluated retrospectively. Available reports of other relevant radiological imaging, medical records, and follow-up PET/CT were reviewed for explanations of the abnormal uptake. RESULTS: Among the 70 physiologic foci, muscular uptake of the lower neck following the surgical and/or radiation therapy of ipsilateral breast (29%), hypermetabolic ovaries (16%) and uterine (10%) uptake during the ovulatory and menstrual phases during the normal menstrual cycle were identified, and also hypermetabolic brown fat in cold-induced thermogenesis (7%), non-specific bowel uptake (35%) were observed. Among the 147 benign lesions, sequelae of the chest wall and breasts following surgical and/or radiation therapy, were often observed (27%). Hypermetabolic thyroid glands were noted as adenomas and chronic thyroiditis (18%). Reactive hyperplasia of cervical or mediastinal lymph nodes (32%), degenerative osteoarthritis and healed fractures (15%), hypermetabolic benign lung lesions (6%) were observed. CONCLUSION: Altered physiologic and benign F-18FDG uptake in the lower cervical muscle and chest wall following ipsilateral breast surgery or radiotherapy were common, and also normal physiologic uptake in ovary and uterus, brown fat, thyroid were considered as predominant findings in womenpatients with breast cancer. Knowledge of these findings might aid in the interpretation of FDG PET/CT in patients with breast cancer.
Authors: Peter Lind; Isabel Igerc; Thomas Beyer; Peter Reinprecht; Klaus Hausegger Journal: Eur J Nucl Med Mol Imaging Date: 2004-04-15 Impact factor: 9.236
Authors: Thomas F Hany; Esmaiel Gharehpapagh; Ehab M Kamel; Alfred Buck; Jean Himms-Hagen; Gustav K von Schulthess Journal: Eur J Nucl Med Mol Imaging Date: 2002-08-08 Impact factor: 9.236